logo
Select company
Select metric
-110.34%Net Margin
VS
Market
13
Sector
39
Industry
67
History
73
$ 2.21Close
$ 0.56 - $ 3.04 52-Week Range
Ticker Information

Ticker

SPRO

Company Name

SPERO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SPERO THERAPEUTICS INC - Net Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRO - Net % Historical data
DateNet Income Common StockNet MarginRevenues
6/30/2025$ -53.6M-110.34%$ 48.58M
3/31/2025$ -69.76M-156.48%$ 44.58M
12/31/2024$ -68.57M-142.91%$ 47.98M
9/30/2024$ 3.51M3.3%$ 106.45M
6/30/2024$ 17.45M14.74%$ 118.46M
3/31/2024$ 23.4M21.09%$ 110.98M
12/31/2023$ 22.81M21.98%$ 103.78M
9/30/2023$ -1.61M-2.08%$ 77.7M
6/30/2023$ -10.08M-18.59%$ 54.23M
3/31/2023$ -26.85M-50.18%$ 53.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SPERO THERAPEUTICS INC's latest trailing twelve months (TTM) Net % stands at -766.14%.
  • Over the past 5 years, SPERO THERAPEUTICS INC's average Net % has been -353.47%.
  • The median Net % for SPERO THERAPEUTICS INC during this period was -149.69%
  • SPERO THERAPEUTICS INC reached its highest Net % over the past 5 years at 21.98%.
  • The lowest Net % recorded by SPERO THERAPEUTICS INC in the same timeframe -1162.35%

SPERO THERAPEUTICS INC's Net % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net % Benchmarks
CompanyNet %
CELU : CELULARITY INC -165.35%CSBR : CHAMPIONS ONCOLOGY INC 5.19%IVVD : INVIVYD INC -238.33%THTX : THERATECHNOLOGIES INC -10.85%PLX : PROTALIX BIOTHERAPEUTICS INC 10.13%BDTX : BLACK DIAMOND THERAPEUTICS INC 20.63%DOMH : DOMINARI HOLDINGS INC -36.01%ENTA : ENANTA PHARMACEUTICALS INC -141.98%CCCC : C4 THERAPEUTICS INC -325.88%EDIT : EDITAS MEDICINE INC -608.88%

Definition of Net Margin

[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Net Inc. Cmn. / Revenues
(=) Net %
Net % for SPERO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -84.68M ] / Revenues [ $ 11.05M ]
(=) Net % [ -766.14% ]

SPRO - Net Margin, Last 5 years

-1162.35%

Minimum

Sep 30, 2022

21.98%

Maximum

Dec 31, 2023

-353.47%

Average

-149.69%

Median

Net % Benchmark Analysis

The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
filtered constituents3.2K
min-64.23%
max69.74%
average4.77%
median5.24%
std19.84%